Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on June 10, 2025
NuggMD Now Serves All Eligible Medical Cannabis Patients Nationwide via Secure Telehealth Platform
GlobeNewswire
·
June 10, 2025
Los Angeles, June 10, 2025 (GLOBE NEWSWIRE) -- NuggMD, the nation’s leading medical marijuana telehealth platform, is proud to announce that it now provides secure access to medical cannabis evaluations in every state where telemedicine is legally …
Mochi Health Launches Enhanced Online Platform to Support Medical Weight Loss Patients Nationwide
GlobeNewswire
·
June 10, 2025
SAN FRANCISCO, June 10, 2025 (GLOBE NEWSWIRE) -- Mochi Health, a physician-founded telehealth company delivering medical weight loss care directly to patients, announced today the launch of its newly upgraded online platform. The improvements are designed …
Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech
GlobeNewswire
·
June 10, 2025
EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary …
Cooper Aerobics Partners with Parker University
GlobeNewswire
·
June 10, 2025
DALLAS, June 10, 2025 (GLOBE NEWSWIRE) -- Cooper Wellness Strategies (CWS), a Cooper Aerobics company, announces a partnership with Parker University, bringing the medically validated CooperFit™ cardiovascular fitness test to two Parker University …
PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors
GlobeNewswire
·
June 10, 2025
San Francisco, June 10, 2025 (GLOBE NEWSWIRE) -- PlushCare, a leading virtual healthcare platform, has announced a significant upgrade to its online Weight Loss Program, enabling greater access to GLP-1-based prescription treatments such as semaglutide …
Enhance.MD Launches Nationwide Telehealth Expansion to Support Men’s Hormonal Health and Medically Supervised Weight Loss
GlobeNewswire
·
June 10, 2025
San Diego, June 10, 2025 (GLOBE NEWSWIRE) -- Enhance.MD, a U.S.-based telehealth provider specializing in men’s hormonal optimization and metabolic wellness, has officially expanded its clinical care services nationwide. This expansion supports a growing …
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
June 10, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, June 10, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …
argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
GlobeNewswire
·
June 10, 2025
ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod RHO data show efgartigimod achieved sustained reduction in autoantibodies and improved functional outcomes in patients …
Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus…
GlobeNewswire
·
June 10, 2025
Consideration composed of a $350m up-front payment and up to $1.0bn in development, regulatory and commercial milestones, along with mid-single to low double-digit royalties on Global Net Sales OTELFINGEN, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- …
ReflexMD Expands Digital Health Access Nationwide with Seamless Prescription Experience
GlobeNewswire
·
June 10, 2025
Claymont, June 10, 2025 (GLOBE NEWSWIRE) -- ReflexMD, a telehealth platform redefining access to medical treatment for everyday health needs, today announced the nationwide availability of its streamlined online service designed to simplify how patients …
BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)
GlobeNewswire
·
June 10, 2025
NORTH BRUNSWICK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for acute and chronic inflammatory diseases, announces that it will conduct a Phase 2 study of rhu-pGSN …
Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial
GlobeNewswire
·
June 10, 2025
SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced it will …
myLAB Box Announces Official Website Update Featuring At-Home Wellness Testing Services
GlobeNewswire
·
June 10, 2025
Los Angeles, June 10, 2025 (GLOBE NEWSWIRE) -- myLAB Box, a nationwide provider of at-home health screening solutions, has updated its official website to expand access to its broad catalog of wellness test kits. Now available across the United States, the …
Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors
GlobeNewswire
·
June 10, 2025
WALTHAM, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the …
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 10, 2025
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 74 …
NetraMark Completes 2025 Annual General Meeting
GlobeNewswire
·
June 10, 2025
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) solutions company transforming clinical trial design in the pharmaceutical …
BrightSpring Announces Secondary Offering of Common Stock
GlobeNewswire
·
June 10, 2025
LOUISVILLE, Ky., June 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced that certain of …
Voting Rights and Shares Capital of the Company
GlobeNewswire
·
June 10, 2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, June 10, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
GlobeNewswire
·
June 10, 2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 10 juin 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …
Celularity Announces Chief Financial Officer Transition
GlobeNewswire
·
June 10, 2025
FLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer (“CFO”), …